Re: New Apabetalone Fabry Disease Publication
|
4
|
Resverlogix Corp.
|
Apr 26, 2022 09:27PM
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
4
|
Resverlogix Corp.
|
Dec 09, 2017 08:00PM
|
Re: BET inhibitors and Pulmonary Hypertension
|
4
|
Resverlogix Corp.
|
Aug 01, 2018 02:18PM
|
Re: ERROR Re: Some wishful thinking....
|
4
|
Resverlogix Corp.
|
Jun 11, 2018 01:01AM
|
Re: Gilead GS-5829 Perspective
|
4
|
Zenith Epigenetics
|
Jul 23, 2017 08:55AM
|
Re: wondering if Dart & co...
|
4
|
Resverlogix Corp.
|
Jun 27, 2019 08:03PM
|
Re: Interesting Trades / Volume .....
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 02:03AM
|
Re: What impact would a PR like this have?
|
4
|
Resverlogix Corp.
|
Jan 29, 2019 04:09PM
|
Re: CVOTs on the Horizon
|
4
|
Resverlogix Corp.
|
Oct 02, 2018 02:53AM
|
Re: Social media footrprint.....
|
4
|
Resverlogix Corp.
|
Nov 23, 2017 10:22PM
|
Re: Number of outstanding warrants + impact
|
4
|
Resverlogix Corp.
|
Nov 25, 2019 08:25PM
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
4
|
Resverlogix Corp.
|
Jan 08, 2018 05:18PM
|
Re: Almost 1.25 years now
|
4
|
Zenith Epigenetics
|
May 31, 2018 01:47AM
|
Re: The “pinks at the open”
|
4
|
Resverlogix Corp.
|
May 07, 2018 11:49AM
|
Re: MD&A out
|
4
|
Resverlogix Corp.
|
Dec 14, 2018 03:40PM
|
Re: No way logical Eastern is selling shares at this point IMO....
|
4
|
Resverlogix Corp.
|
Aug 13, 2019 02:07PM
|
Re: Rebuys start at $2.28
|
4
|
Resverlogix Corp.
|
Aug 09, 2018 06:31PM
|
Re: Third Eye and Topline
|
4
|
Resverlogix Corp.
|
Dec 20, 2018 06:32PM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
4
|
Resverlogix Corp.
|
Apr 16, 2021 01:16AM
|
Re: Broker Meeting 23 Feb
|
4
|
Resverlogix Corp.
|
Mar 01, 2017 02:28AM
|